ORGANICELL REGENERATIVE MEDICINE IN | 4: Statement of changes in beneficial ownership of securities-Director GLAUSER STEVEN JERRY
Apr 2 16:17 ET
ORGANICELL REGENERATIVE MEDICINE IN | 4: Statement of changes in beneficial ownership of securities-Director Stearn Leathem S
Apr 2 16:17 ET
ORGANICELL REGENERATIVE MEDICINE IN | 4: Statement of changes in beneficial ownership of securities-Director Singh Gurvinder Pal
Apr 2 16:17 ET
ORGANICELL REGENERATIVE MEDICINE IN | 4: Statement of changes in beneficial ownership of securities-Director Bretz Charles Luther
Apr 2 16:16 ET
ORGANICELL REGENERATIVE MEDICINE IN | 8-K: Current report
Apr 2 16:11 ET
ORGANICELL REGENERATIVE MEDICINE IN | 10-Q: Quarterly report
Mar 18 16:23 ET
ORGANICELL REGENERATIVE MEDICINE IN | 8-K: Current report
Mar 4 17:51 ET
ORGANICELL REGENERATIVE MEDICINE IN | 8-K: Current report
Feb 26 16:10 ET
ORGANICELL REGENERATIVE MEDICINE IN | 10-K: Annual report
Jan 29 16:40 ET
ORGANICELL REGENERATIVE MEDICINE IN | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Chief Executive Officer Leider Harry L.
Dec 21, 2023 16:01 ET
ORGANICELL REGENERATIVE MEDICINE IN | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Leider Harry L.
Dec 20, 2023 16:05 ET
ORGANICELL REGENERATIVE MEDICINE IN | DEF 14C: Definitive information statements
Dec 20, 2023 06:30 ET
ORGANICELL REGENERATIVE MEDICINE IN | 8-K: Current report
Dec 12, 2023 16:15 ET
No Data
No Data